Beltsville, MD, February 22, 2010 – BioServe, a leading provider of human biomaterial and genomic research services, today announced that it has completed validation testing of the Oragene•DNA saliva collection kits and has joined DNA Genotek’s Partner Program. Now, BioServe can offer customers a comprehensive testing platform for extraction and genetic analysis for Oragene•DNA samples.
BioServe has validated Oragene•DNA kits for use within its DNA extraction and genotyping service, including sample quantification and normalization; whole genome amplification; multiplex-based genotyping, expression analysis and sample archiving.
“Validating Oragene DNA kits for use with our genomic services is consistent with our goal of providing customers the highest quality and most economical services,” said Rama Modali, president, BioServe. “Partnering with DNA Genotek, we can now offer our customers a best-in-class solution for processing Oragene•DNA samples including extraction and genotyping from saliva, which is in keeping with the high standards customers expect from BioServe.”
“DNA Genotek’s Partner Program is designed to facilitate the development of strong collaborations between the customers who use our technologies and our global partners. BioServe Biotechnologies has fully met all the program criteria and has proven expertise in working with our products,” said Ian Curry, president and CEO, DNA Genotek, Inc. “We look forward to further developing this relationship with BioServe and providing our customers with another validated option for processing the DNA samples collected with Oragene•DNA.”